Parathyroid Disorders Market Developments, Trends, and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Parathyroid Disorders Market covers analysis by Type ( Hyperparathyroidism (HPT), Parathyroid Cancer, Hypoparathyroidism ); Diagnosis ( Blood Tests, Imaging Tests, Urine Tests ); Treatment ( Surgery, Radiation Therapy, Drugs, Others ); End User ( Hospitals and Clinics, Diagnostic Centers, Drug Stores, Pharmacies, Others ) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Sep 2025
  • Report Code : TIPRE00007614
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

The Parathyroid Disorders Market is expected to register a CAGR of 6.7% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The report undertakes a comprehensive analysis of the Parathyroid Disorders market, surveying its current state and future trends and actual driving factors. The report details the different types of parathyroid disorders, such as primary hyperparathyroidism, secondary hyperparathyroidism, and hypoparathyroidism, their symptoms, and associated complications. The study further explores the diagnostic methods used for these disorders, which include blood tests, imaging studies, and genetic testing. The treatment options available, including medical management, surgical interventions, and emerging therapies, are also considered in the report. This report further examines the market landscape, the key players, and their strategies and competitive dynamics. This report is used as a value source for stakeholders in the healthcare industry - the pharmaceutical companies, medical device manufacturers, healthcare providers, and investors - through insights into the market size, growth prospects, and regional trends.

Purpose of the Report

The report Parathyroid Disorders Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Parathyroid Disorders Market Segmentation

Type

  • Hyperparathyroidism Parathyroid Cancer
  • Hypoparathyroidism

Diagnosis

  • Blood Tests
  • Imaging Tests
  • Urine Tests

Treatment

  • Surgery
  • Radiation Therapy
  • Drugs

End User

  • Hospitals and Clinics
  • Diagnostic Centers
  • Drug Stores
  • Pharmacies

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Parathyroid Disorders Market: Strategic Insights

parathyroid-disorders-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Parathyroid Disorders Market Growth Drivers

  • Rising Incidences of parathyroid: Several influential factors have been pushing the parathyroid disorders market upward. The incidence rate has been observed to be highly increased among the aging population. As people stay healthier for longer, the chances of them getting afflicted by age-related diseases like parathyroid disorders go up.
  • Improved Diagnostic Methodology: Better technologies that evolve with time improve diagnostic methodologies which include blood tests and imaging studies, thus helping determine the conditions resulting from parathyroid disorders earlier and more accurately. This has increased the cure rate for the conditions under discussion.
  • Growing Awareness: Growing awareness among healthcare providers and the public at large regarding parathyroid diseases accelerates the urgent demand for viable treatment solutions. This is yet further accelerated by increased healthcare spending and efforts by the government toward increasing access to healthcare facilities. However, in addition to all these, there is still research coming in on new and innovative therapies and surgical procedures. Personalized medicine is gaining momentum, and this trend further supports growth within this market.
  • Advancements in Drug Development: Innovations in therapeutic options, including calcimimetics, parathyroid hormone (PTH) analogs, and biologics, offer opportunities to address unmet needs in managing these disorders.

Parathyroid Disorders Market Future Trends

  • Advancements in Minimally Invasive Surgical Techniques: Further definition of the future of this parathyroid disorders market will be made by advancement in minimally invasive surgical techniques, such as robotic surgery and video-assisted parathyroidectomy, that will improve patient outcomes and reduce recovery time. Additional channels for patients who are not good surgical candidates have been opened by new medical therapies, such as calcimimetics and bisphosphonates for the treatment of secondary hyperparathyroidism. Advances in technologies that would increase access, especially for all underserved areas, have brought about more uptakes of telemedicine and remote patient monitoring.
  • Personalised Medicines: Rising emphasis on personalized medicine and focusing on the precision medicine approach will empower further strategies based on the specifics of individual patients for individualized therapy approaches. Continuous research unraveling mechanisms underlying these parathyroid disorders would surely be followed by targeted therapies and preventive interventions.
  • Development of Combination Therapies: Combining PTH analogs with vitamin D analogs or other medications to optimize treatment outcomes offers a promising avenue for new product development.

Parathyroid Disorders Market Opportunities

  • Advancement in diagnostic: The parathyroid disorders market remains vast and has lots of scope for growth and innovation. Parathyroid disorders are increasingly common, and advancement in diagnostic and therapeutic technologies holds lots of promise. Continually improving with minimal surgical techniques, especially with robotic surgery, the patient outcomes will continue to improve while the periods of recovery shorten. It has introduced drugs such as calcimimetics and bisphosphonates into emerging fields of medicine, which shall be used in poor surgical candidates as a second-line therapy.
  • Growing interest in Individualization: There is an increasingly growing interest in individualization and precision medicine. The successful introduction of targeted therapies demonstrates an interest in such a strategy based on the needs of a specific patient.
  • Integration of Technology: Telemedicine and remote patient monitoring may increase the availability of care for such underserved areas. These trends open up market players a chance to meet and expand the demand for effective treatments and diagnostic tools by those suffering from disorders of parathyroids.

Parathyroid Disorders Market Regional Insights

The regional trends and factors influencing the Parathyroid Disorders Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Parathyroid Disorders Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

parathyroid-disorders-market-global-geography
  • Get the Regional Specific Data for Parathyroid Disorders Market

Parathyroid Disorders Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 6.7%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type
  • Hyperparathyroidism Parathyroid Cancer
  • Hypoparathyroidism
By Diagnosis
  • Blood Tests
  • Imaging Tests
  • Urine Tests
By Treatment
  • Surgery
  • Radiation Therapy
  • Drugs
By End User
  • Hospitals and Clinics
  • Diagnostic Centers
  • Drug Stores
  • Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Alcon Laboratories, Inc.
  • Amgen Inc.
  • Bayer Healthcare
  • Becton
  • Dickinson and Company
  • Eli Lilly, Ethicon, Inc.
  • Medtronic
  • Merck
  • Smith & Nephew plc

  • Parathyroid Disorders Market Players Density: Understanding Its Impact on Business Dynamics

    The Parathyroid Disorders Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Parathyroid Disorders Market are:

    1. Alcon Laboratories, Inc.
    2. Amgen Inc.
    3. Bayer Healthcare
    4. Becton
    5. Dickinson and Company

    Disclaimer: The companies listed above are not ranked in any particular order.


    parathyroid-disorders-market-cagr

    • Get the Parathyroid Disorders Market top key players overview

    Key Selling Points

    • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Parathyroid Disorders Market, providing a holistic landscape.
    • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
    • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
    • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

    The research report on the Parathyroid Disorders Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


    Frequently Asked Questions

    Which are the leading players operating in the Parathyroid Disorders Market?

    The leading players of the market are: Alcon Laboratories, Inc., Amgen Inc., Bayer Healthcare, Becton, Dickinson and Company, Ethicon, Inc., Medtronic Merck, Smith & Nephew plc, Teva Pharmaceutical Industries Ltd.

    What are the deliverable formats of the Parathyroid Disorders Market report?

    The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

    What are the options available for the customization of this report? 

    Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

    What are the future trends of the Parathyroid Disorders Market?

    The future of the parathyroid disorders market is influenced by several trends. Improved patient outcomes through the advancement of minimally invasive surgical techniques, such as robotic surgery, are driving the market forward. Novel medical therapies, including calcimimetics and bisphosphonates, open up new treatment channels. Improvements in patient access with telemedicine and remote monitoring further advance the space. Moving forward, increased personalization will be realized, enabling more tailored treatment strategies. Further research and discovery of targeted therapies and preventive interventions will ultimately push market growth forward.

    What is the expected CAGR of the Parathyroid Disorders Market?

    Parathyroid Disorders Market is expected to grow at a CAGR of 6.7% between 2023-2031

    What are the driving factors impacting the Parathyroid Disorders Market?

    Driving Factors of the Parathyroid Disorders Market: The growing population of the aged is on the leading edge in terms of increasing prevalence of parathyroid disorders. The advancement in diagnostic techniques like blood tests and imaging studies has enabled better and earlier diagnosis. Increasing expenditure on healthcare, as well as efforts from the government to enhance health care accessibility, also catalyze market growth. Developing innovative therapies and surgical techniques, as well as the intensifying focus on personalized medicine, are expected to propel future market growth.

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    The List of Companies

    1. Alcon Laboratories, Inc.
    2. Amgen Inc.
    3. Bayer Healthcare
    4. Becton
    5. Dickinson and Company
    6. Eli Lilly, Ethicon, Inc.
    7. Medtronic
    8. Merck
    9. Smith & Nephew plc
    10. Teva Pharmaceutical Industries Ltd.
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo